Cytokinetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CEORobert I. Blum, MBA
CEORobert I. Blum, MBA
Employees423
Employees423
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded1997
Founded1997
Employees423
Employees423
CYTK Key Statistics
Market cap5.63B
Market cap5.63B
Price-Earnings ratio-9.01
Price-Earnings ratio-9.01
Dividend yield—
Dividend yield—
Average volume1.39M
Average volume1.39M
High today$48.85
High today$48.85
Low today$47.29
Low today$47.29
Open price$48.13
Open price$48.13
Volume337.08K
Volume337.08K
52 Week high$110.25
52 Week high$110.25
52 Week low$45.66
52 Week low$45.66
CYTK News
Seeking Alpha 4d
Cytokinetics' aficamten application validated by EU regulatorsCytokinetics (NASDAQ:CYTK) said EU regulators have validated the market application for its drug aficamten for the treatment of obstructive hypertrophic cardiom...
Analyst ratings
78%
of 18 ratingsBuy
77.8%
Hold
22.2%
Sell
0%